Although the mRNA expression of stemness markers, such as SOX2, c-MYC, and NANOG, was reduced by YTHDC2 knockdown, the alteration of gene expression pattern was not the same for all of breast cancer cell lines. The gene discussed is NANOG; the disease is breast carcinoma.